BIORETEC OY Total Liabilities
BIORETEC OY total liabilities. Based on the latest financial reports, BIORETEC OY (0TN) has total liabilities worth €1.92 Million EUR (≈ $2.24 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check financial resilience of BIORETEC OY to evaluate the company's liquid asset resilience ratio.
Total Liabilities of BIORETEC OY (2021–2025)
Total liabilities of BIORETEC OY from 2021 to 2025. This chart illustrates how BIORETEC OY's total liabilities have evolved over time, based on quarterly financial data.
BIORETEC OY Competitors by Total Liabilities
The table below lists competitors of BIORETEC OY ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Karyon Industries Bhd
KLSE:0054
|
Malaysia | RM26.80 Million |
|
Bridgemarq Real Estate Services Inc
TO:BRE
|
Canada | CA$205.78 Million |
|
DistIT AB (publ)
ST:DIST
|
Sweden | Skr394.40 Million |
|
Neometals Ltd
AU:NMT
|
Australia | AU$8.74 Million |
|
J and Friends Holdings Limited
NASDAQ:JF
|
USA | $22.85 Million |
|
Marti Otel Isletmeleri AS
IS:MARTI
|
Turkey | TL9.74 Billion |
|
Crookes Brothers Ltd
JSE:CKS
|
South Africa | ZAC892.52 Million |
|
HM Inwest S.A.
WAR:HMI
|
Poland | zł157.19 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down BIORETEC OY's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see 0TN total asset value.
Liquidity & Leverage Metrics
BIORETEC OY Total Liabilities Ratios Explained
BIORETEC OY total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 5.18 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.20 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.16 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how BIORETEC OY's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for BIORETEC OY (2021–2025)
The table below shows the annual total liabilities of BIORETEC OY from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | €1.92 Million ≈ $2.24 Million |
+10.39% |
| 2024-12-31 | €1.74 Million ≈ $2.03 Million |
-28.46% |
| 2023-12-31 | €2.43 Million ≈ $2.84 Million |
+54.95% |
| 2022-12-31 | €1.57 Million ≈ $1.83 Million |
-63.08% |
| 2021-12-31 | €4.24 Million ≈ $4.96 Million |
-- |
About BIORETEC OY
Bioretec Oy, a medical device company, develops, manufactures, and markets bioresorbable orthopedic implants for the repair of bone and soft tissue injuries in children and adults worldwide. The company offers Activa IM-Nail, a bioabsorbable option for pediatric forearm intramedullary nailing; ActivaNail, an implant that is be used in upper or lower limbs to ensure successful bone regeneration; A… Read more